A new clinical trial led by researchers from Brigham and Women's Hospital and Harvard Medical School, both in Boston, will examine how use of a data-driven sleep training app affects the health, productivity and safety of Brigham and Women's staff.
The trial will begin in January 2020 and will be led by Charles Czeisler, MD, PhD, a senior physician in the Brigham and Women's division of sleep and circadian disorders and the Baldino professor of sleep medicine at Harvard Medical School. Dr. Czeisler's team will monitor hospital employees' use of the Dayzz sleep app, which is currently available to U.S. employers and provides workers with personalized sleep training plans.
"Sleep deficiency is a hidden cost of our tech-driven, 24/7 society. Our goal is to help a representative workforce population working within a large corporation get more, higher-quality sleep, which we expect will lead to increased productivity, mood, alertness and energy, while decreasing sick days and healthcare costs over the nine-month follow up period," Mairav Cohen-Zion, PhD, Dayzz's chief science officer, said in a news release.